Stonvex publishes market data and research only. Not investment advice. Not a registered investment advisor. Read disclaimer.

ZYME

Live52w high -13.9%

Log in Get Started

52w high -13.9%

Side-by-side peer comparison: valuation, growth, margin, and Activity Index.

No peer cohort available for ZYME

Neither our curated theme map nor Finnhub's sector-similar list returned peers for ZYME. Common for brand-new IPOs, very small caps, and pink-sheet OTC tickers Finnhub doesn't enrich.